Celadon Pharmaceuticals Plc (CEL.L)
- Previous Close
14.00 - Open
0.00 - Bid 12.00 x --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 85.00 - Volume
100,000 - Avg. Volume
217,824 - Market Cap (intraday)
10.327M - Beta (5Y Monthly) -0.11
- PE Ratio (TTM)
-- - EPS (TTM)
-0.08 - Earnings Date Jun 5, 2025 - Jun 12, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
celadonpharma.com/27
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: CEL.L
View MorePerformance Overview: CEL.L
Trailing total returns as of 6/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CEL.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CEL.L
View MoreValuation Measures
Market Cap
9.64M
Enterprise Value
14.40M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
68.24
Price/Book (mrq)
3.97
Enterprise Value/Revenue
110.78
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-34.40%
Return on Equity (ttm)
-190.71%
Revenue (ttm)
130k
Net Income Avi to Common (ttm)
-5.23M
Diluted EPS (ttm)
-0.08
Balance Sheet and Cash Flow
Total Cash (mrq)
16k
Total Debt/Equity (mrq)
194.82%
Levered Free Cash Flow (ttm)
-4.4M